Innovating Works

Toleranzia AB

Desconocido
SciLifeLab PULSE: SciLifeLab Programme for fUture Leaders in life SciencE SciLifeLab PULSE is a MSCA-COFUND postdoctoral programme of excellence in Life Sciences coordinated by the Swedish research infrastructure S...
2024-09-16 - 2030-08-31 | Financiado
TOL2: An effective and safe targeted therapy for treatment of Myasthenia gravis TOLERANZIA AB tramitó un H2020: H2020-EIC-SMEInst-2018-2020 Myasthenia gravis (MG) is a rare disease affecting 2/10.000 people. Although being a rare disease, MG is the most common chronic autoimmune...
2019-01-28 - 2019-05-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.